Annual accounts receivable:
$1.50M-$1.20M(-44.44%)Summary
- As of today (September 10, 2025), DNLI annual accounts receivable is $1.50 million, with the most recent change of -$1.20 million (-44.44%) on December 31, 2024.
- During the last 3 years, DNLI annual accounts receivable has fallen by -$12.20 million (-89.05%).
- DNLI annual accounts receivable is now -89.05% below its all-time high of $13.70 million, reached on December 31, 2021.
Performance
DNLI Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$1.40M-$300.00K(-17.65%)Summary
- As of today (September 10, 2025), DNLI quarterly accounts receivable is $1.40 million, with the most recent change of -$300.00 thousand (-17.65%) on June 30, 2025.
- Over the past year, DNLI quarterly accounts receivable has stayed the same.
- DNLI quarterly accounts receivable is now -90.80% below its all-time high of $15.22 million, reached on June 30, 2021.
Performance
DNLI Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
DNLI Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.4% | 0.0% |
| 3 y3 years | -89.0% | - |
| 5 y5 years | - | - |
DNLI Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -89.0% | at low | -72.0% | at low |
| 5 y | 5-year | -89.0% | at low | -90.8% | at low |
| alltime | all time | -89.0% | >+9999.0% | -90.8% | >+9999.0% |
DNLI Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $1.40M(-17.6%) |
| Mar 2025 | - | $1.70M(+13.3%) |
| Dec 2024 | $1.50M(-44.4%) | $1.50M(+7.1%) |
| Sep 2024 | - | $1.40M(0.0%) |
| Jun 2024 | - | $1.40M(-48.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $2.70M(-46.0%) | $2.70M(-46.0%) |
| Dec 2022 | $5.00M(-63.5%) | $5.00M(-63.5%) |
| Dec 2021 | $13.70M(+86.0%) | $13.70M(-10.0%) |
| Jun 2021 | - | $15.22M(+106.7%) |
| Dec 2018 | $7.36M(>+9900.0%) | $7.36M(>+9900.0%) |
| Dec 2017 | $0.00 | $0.00 |
FAQ
- What is Denali Therapeutics Inc. annual accounts receivable?
- What is the all time high annual accounts receivable for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. annual accounts receivable year-on-year change?
- What is Denali Therapeutics Inc. quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. quarterly accounts receivable year-on-year change?
What is Denali Therapeutics Inc. annual accounts receivable?
The current annual accounts receivable of DNLI is $1.50M
What is the all time high annual accounts receivable for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high annual accounts receivable is $13.70M
What is Denali Therapeutics Inc. annual accounts receivable year-on-year change?
Over the past year, DNLI annual accounts receivable has changed by -$1.20M (-44.44%)
What is Denali Therapeutics Inc. quarterly accounts receivable?
The current quarterly accounts receivable of DNLI is $1.40M
What is the all time high quarterly accounts receivable for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high quarterly accounts receivable is $15.22M
What is Denali Therapeutics Inc. quarterly accounts receivable year-on-year change?
Over the past year, DNLI quarterly accounts receivable has changed by $0.00 (0.00%)